Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management of advanced bladder cancer in the era of targeted therapies.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology - 1 Jun 2015

Soave A, Engel O, Von Amsberg G, Becker A, Dahlem R, Shariat S F, Fisch M, Rink M

Abstract excerpt

Systemic chemotherapy is the standard treatment of advanced and metastatic urothelial carcinoma of the bladder (UCB). Unfortunately, systemic chemotherapy is ineffective in a significant number of patients, while side effects occur frequently. Detailed molecular-genetic investigations revealed a broad heterogeneity of underlying genomic mutations in UCB and led to the detection of cancer-specific therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Evidence-Based Medicine

Share to Immunotherapy

Share to Molecular Targeted Therapy

Share to Urinary Bladder Neoplasms

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 25604695

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management of advanced bladder cancer in the era of targeted therapies.PMID 25604695Read ↗

Molecular targets and targeted therapies in bladder cancer managementSemantic proximity Read ↗

Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses.Semantic proximity Read ↗

Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing.Semantic proximity Read ↗

The Cancer Genome Atlas Project in Bladder Cancer.Semantic proximity Read ↗

Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.Semantic proximity Read ↗

Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer.Semantic proximity Read ↗

Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current DevelopmentSemantic proximity Read ↗

Frontiers in Bladder Cancer Genomic ResearchSemantic proximity Read ↗

Similar genetic profile in early and late stage urothelial tract cancer.Semantic proximity Read ↗

The role of genomics in the management of advanced bladder cancer.Semantic proximity Read ↗

New discoveries in the molecular landscape of bladder cancerSemantic proximity Read ↗

Molecular classification of urothelial bladder carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.